These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32251706)

  • 1. Evolving functions of Dickkopf-1 in cancer and immunity.
    Jaschke N; Hofbauer LC; Göbel A; Rachner TD
    Cancer Lett; 2020 Jul; 482():1-7. PubMed ID: 32251706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dorsomorphin: A novel inhibitor of Dickkopf-1 in breast cancer.
    Jaschke N; Kleymann A; Hofbauer LC; Göbel A; Rachner TD
    Biochem Biophys Res Commun; 2020 Apr; 524(2):360-365. PubMed ID: 32001001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the Wnt pathway in cancer: the emerging role of Dickkopf-3.
    Veeck J; Dahl E
    Biochim Biophys Acta; 2012 Jan; 1825(1):18-28. PubMed ID: 21982838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiated suppression of Dickkopf-1 in breast cancer by combined administration of the mevalonate pathway inhibitors zoledronic acid and statins.
    Göbel A; Browne AJ; Thiele S; Rauner M; Hofbauer LC; Rachner TD
    Breast Cancer Res Treat; 2015 Dec; 154(3):623-31. PubMed ID: 26515701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dickkopf-1: Current knowledge and related diseases.
    Huang Y; Liu L; Liu A
    Life Sci; 2018 Sep; 209():249-254. PubMed ID: 30102902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of Dickkopf-1 in joint remodeling and fibrosis: A link connecting spondyloarthropathies and scleroderma?
    Klavdianou K; Liossis SN; Sakkas L; Daoussis D
    Semin Arthritis Rheum; 2017 Feb; 46(4):430-438. PubMed ID: 27670695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer.
    Aguilera O; Fraga MF; Ballestar E; Paz MF; Herranz M; Espada J; García JM; Muñoz A; Esteller M; González-Sancho JM
    Oncogene; 2006 Jul; 25(29):4116-21. PubMed ID: 16491118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer.
    González-Sancho JM; Aguilera O; García JM; Pendás-Franco N; Peña C; Cal S; García de Herreros A; Bonilla F; Muñoz A
    Oncogene; 2005 Feb; 24(6):1098-103. PubMed ID: 15592505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dickkopf-1 as a promising therapeutic target for autoimmune diseases.
    Tao SS; Cao F; Sam NB; Li HM; Feng YT; Ni J; Wang P; Li XM; Pan HF
    Clin Immunol; 2022 Dec; 245():109156. PubMed ID: 36257529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paracrine and autocrine regulation of gene expression by Wnt-inhibitor Dickkopf in wild-type and mutant hepatocytes.
    Hartung N; Benary U; Wolf J; Kofahl B
    BMC Syst Biol; 2017 Oct; 11(1):98. PubMed ID: 29029622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Multifaceted Role of Human Dickkopf-3 (DKK-3) in Development, Immune Modulation and Cancer.
    Mourtada J; Thibaudeau C; Wasylyk B; Jung AC
    Cells; 2023 Dec; 13(1):. PubMed ID: 38201279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dickkopf-1 inhibits thyroid cancer cell survival and migration through regulation of β-catenin/E-cadherin signaling.
    Cho SW; Lee EJ; Kim H; Kim SH; Ahn HY; Kim YA; Yi KH; Park DJ; Shin CS; Ahn SH; Cho BY; Park YJ
    Mol Cell Endocrinol; 2013 Feb; 366(1):90-8. PubMed ID: 23261982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Wnt antagonist DICKKOPF-1 gene is induced by 1alpha,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells.
    Aguilera O; Peña C; García JM; Larriba MJ; Ordóñez-Morán P; Navarro D; Barbáchano A; López de Silanes I; Ballestar E; Fraga MF; Esteller M; Gamallo C; Bonilla F; González-Sancho JM; Muñoz A
    Carcinogenesis; 2007 Sep; 28(9):1877-84. PubMed ID: 17449905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the Wnt inhibitor Dickkopf-1 is required for the induction of neural markers in mouse embryonic stem cells differentiating in response to retinoic acid.
    Verani R; Cappuccio I; Spinsanti P; Gradini R; Caruso A; Magnotti MC; Motolese M; Nicoletti F; Melchiorri D
    J Neurochem; 2007 Jan; 100(1):242-50. PubMed ID: 17064353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DICKKOPF-4 is induced by TCF/beta-catenin and upregulated in human colon cancer, promotes tumour cell invasion and angiogenesis and is repressed by 1alpha,25-dihydroxyvitamin D3.
    Pendás-Franco N; García JM; Peña C; Valle N; Pálmer HG; Heinäniemi M; Carlberg C; Jiménez B; Bonilla F; Muñoz A; González-Sancho JM
    Oncogene; 2008 Jul; 27(32):4467-77. PubMed ID: 18408752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dickkopf-1 enhances inflammatory interaction between platelets and endothelial cells and shows increased expression in atherosclerosis.
    Ueland T; Otterdal K; Lekva T; Halvorsen B; Gabrielsen A; Sandberg WJ; Paulsson-Berne G; Pedersen TM; Folkersen L; Gullestad L; Oie E; Hansson GK; Aukrust P
    Arterioscler Thromb Vasc Biol; 2009 Aug; 29(8):1228-34. PubMed ID: 19498175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt signaling in osteosarcoma.
    Lin CH; Ji T; Chen CF; Hoang BH
    Adv Exp Med Biol; 2014; 804():33-45. PubMed ID: 24924167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dickkopf-1 mediated tumor suppression in human breast carcinoma cells.
    Mikheev AM; Mikheeva SA; Maxwell JP; Rivo JV; Rostomily R; Swisshelm K; Zarbl H
    Breast Cancer Res Treat; 2008 Nov; 112(2):263-73. PubMed ID: 18157634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Dickkopf-1 as a potential prognostic marker in pancreatic ductal adenocarcinoma.
    Liu DJ; Xie YX; Liu XX; Huo YM; Yang MW; Fu XL; Liu W; Yang JY; Li J; Hua R; Liu PF; Sun YW; Zhang JF
    Cell Cycle; 2017; 16(17):1622-1629. PubMed ID: 28749252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer.
    Aguilera Ó; González-Sancho JM; Zazo S; Rincón R; Fernández AF; Tapia O; Canals F; Morte B; Calvanese V; Orgaz JL; Niell N; Aguilar S; Freije JM; Graña O; Pisano DG; Borrero A; Martínez-Useros J; Jiménez B; Fraga MF; García-Foncillas J; López-Otín C; Lafarga M; Rojo F; Muñoz A
    Oncotarget; 2015 Mar; 6(8):5903-17. PubMed ID: 25788273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.